ArticleDigestive diseases and sciences2026
Serum Renin: An Early Biomarker for Predicting Severe Acute Pancreatitis.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimAcute pancreatitis stems from pancreatic acinar injury leading to autodigestion and inflammation. Most cases are self-limiting, but severe acute pancreatitis involves prolonged hospitalization and mortality up to 50%. Current predictors lack early sensitivity or require 24-48 hours for assessment. Reliable early biomarkers are essential for timely triage and de-escalation. This study examined admission serum renin as an early severe acute pancreatitis predictor, hypothesizing renin-angiotensin system activation from hypovolemia.
methodsIn this prospective cohort study conducted at a tertiary center from October 12, 2023, to September 29, 2024, serum renin levels were measured upon admission in 240 patients with acute pancreatitis and the predictive performance for severe acute pancreatitis was compared with the APACHE II and BISAP scores calculated at the 24th hour of admission, as well as the Ranson's criteria calculated at 48th hour of admission.
resultsThe cutoff of ≥ 2400 pg/mL yielded an AUC of 0.870 (95% CI: 0.784-0.925), with a sensitivity of 86.1% and negative predictive value of 97.6%, performing as effectively as the scoring systems. High-renin patients had high rates of necrotizing pancreatitis, severe acute pancreatitis (32.9% vs. 2.4%), ICU admission (32.9% vs. 9.1%), and mortality (13.2% vs. 1.2%). Decision curve analysis showed serum renin's highest net benefit at 10-20% thresholds.
conclusionsAdmission serum renin emerges as a robust early biomarker for predicting severe acute pancreatitis, with high sensitivity and negative predictive value enabling timely triage and de-escalation. Its immediate accessibility surpasses delayed tools, potentially reducing mortality and costs.
Indexed as
Identifiers
41364353What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.